This hints at the possibility that loss of p53 on chromosome 17pl3, besides TP53 point mutations, may result in the inactivation of both normal p53 alleles and the progression of CML to the AP. Here, TP53 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.